Thread by @cnnphilippines

Samahan si @ruthcabal15 sa #NewsroomNgayon — balita at serbisyo para sa Pilipino.

💻 Facebook bit.ly/3pL6eHG
📱 Live stream cnn.ph/1LXc9jG
📺 Free TV ch. 9, Cignal ch. 10, Sky Cable ch. 14

DOST Usec. Rowena Guevarra on ivermectin clinical trial vs. COVID-19: Layon ng pag-aaral na ito na malaman talaga ang safety, efficacy, at saka effect on viral clearance nito.

Related: bit.ly/3pZs3n5

DOST Usec. Guevarra notes the anti-parasitic drug will be tested as cure for COVID-19.

DOST Usec. Guevarra on patient recruitment: Kapag kinulang pa tayo ng participants, magre-recruit din tayo sa Region 3 at 11.

A total of 1,464 participants will be needed for the study.

DOST Usec. Guevarra says volunteers for the trial will be given allowance: Hindi namin siya tinatawag na bayad. Parang ano siya, allowance, dahil hindi ka nagtrabaho that day.

DOST Usec. Guevarra on lagundi providing "symptomatic relief": Na-conclude ng ating project team na ang lagundi can be safely used for symptomatic, mild COVID-19.

DOST Usec. Guevarra says tawa-tawa, an herbal supplement, is also proven to be "effective" against COVID-19: Maganda ang naging effect (sa study). Nakita pa nila na within 3 to 5 days, nagkakaroon na ng ginhawa itong mga pasyente.

DOST Usec. Guevarra: Naiibsan 'yung symptoms 'pag nag-take sila ng tawa-tawa saka itong lagundi.

She stresses both are FDA-approved.

DOST Usec. Guevarra on the use of virgin coconut oil for COVID-19: Mas umiikli 'yung recovery time, tapos, hindi natutuloy 'yung pagiging severe nung mga kaso ng nasa facility.

What's covered under the DOST's scholarship program for science undergraduates?

Usec. Guevarra says these include the tuition fee, stipend worth ₱7,000 per month, transportation, book allowance, and insurance until graduation.